Abstract:Abstract Despite the vital activity of many compounds, they lack that effectiveness due to their low solubility in water. Unfortunately, for this reason, rutin often leads to low tissue permeability and insufficient bioavailability, which has greatly limited its pharmacological utility. Therefore, the present investigation is designed to overcome this problem by formulating the rotin to rotin nanocrystals (RNCs) with studying their some pharmacological applications in vitro and in silico. RNCs were created via the ultrasonication approach and showed a spherical shape via Transmission electron microscopy with a mean particle size of 27 nm. RNCs reflected inhibitory action against Helicobacter pylori with an inhibition zone (IZ) of 22.67 mm compared to rutin (IZ of 18 mm) and standard control (IZ of 19.5 mm). RNCs exhibited less minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) (7.8 μg/mL) than rutin (62.5 μg/mL). The MBC/MIC index of rutin and RNCs indicated their bactericidal properties. RNCs were more acutely ( 92.12%) than rutin (85.43%) for inhibition the H. pylori biofilm formation. A promising half maximal inhibitory concentration (IC 50 ) (6.85 μg/mL) was recorded using RNCs for urease inhibition compared to the IC 50 value of rutin (97.8 μg/mL). The activity of rutin and RNCs was tested against cancer cells of human colon cancer (HT-29) and normal Vero cells. IC 50 values of RNCs were less 168.23 ± 1.15 μg/mL and 297.69 ± 4.23 μg/mL than the IC 50 values of rutin 184.96 ± 4.33 μg/mL and 335.31 ± 2.02 μg/mL against HT-29 cells and normal Vero cells, respectively. Different percentages (72.2, 77.3, and 81.9%) of hemolysis inhibition were recorded using RNCs, but 63.6, 68.9, 73.6, and 80.6% were obtained using rutin at 600, 800, and 1000 μg/mL, respectively. Butyrylcholinesterase (BChE) inhibition % was documented at a lower IC 50 value for RNCs (12.74 μg/mL) than the IC 50 of rutin (18.15 μg/mL). The target molecule underwent molecular docking research against H. pylori [Protein Data Bank (PDB) code: 4HI0], HT-29 cells (PDB code: 2HQ6), and BChE (PDB code: 6EMI) in order to enhance the interactions between rutin and the chosen receptors and to estimate its molecular operating environment (MOE) affinity scoring. Rutin has predicted strong binding interactions and potent activity against the examined proteins 4HI0, 2HQ6, and 6EMI with low binding scores of − 7.47778 kcal/mol, − 7.68511 kcal/mol, and − 9.50333 kcal/mol, respectively.

In‐vitro evaluation of antimicrobial and anti‐inflammatory efficacy of the gelatin‐β‐cyclodextrin hydrogels as biodegradable carriers for rutin

Development of Gum-Acacia-Stabilized Silver Nanoparticles Gel of Rutin against Candida albicans

Albumin-Based Hydrogel Films Covalently Cross-Linked with Oxidized Gellan with Encapsulated Curcumin for Biomedical Applications

In situ Crosslinking System of Gelatin with Acrylated β-cyclodextrin Towards the Fabrication of Hydrogels for Sustained Drug Release

Microemulsion and microemulsion gel formulation for transdermal delivery of rutin: Optimization, in-vitro/ex-vivo evaluation and SPF determination

Study of Hydroxypropyl β-Cyclodextrin and Puerarin Inclusion Complexes Encapsulated in Sodium Alginate-Grafted 2-Acrylamido-2-Methyl-1-Propane Sulfonic Acid Hydrogels for Oral Controlled Drug Delivery

β-Cyclodextrin/PVP-Stabilized Nanocrystal Gel for Dual Release of Rutin and Thymoquinone for Wound Healing

Improvement of Cross-linked Alginate Hydrogel Microparticles Loaded with Galangin-β-Cyclodextrin Complex by Response Surface Methodology

Self-crosslinked chitosan/dialdehyde xanthan gum blended hypromellose hydrogel for the controlled delivery of ampicillin, minocycline and rifampicin

Preparation and antibacterial properties of curcumin-loaded cyclodextrin-grafted chitosan hydrogel

In Vitro Biological Evaluation of an Alginate-Based Hydrogel Loaded with Rifampicin for Wound Care

Preparation Characterization and Blood Compatibility Studies of Silk Fibroin / Gelatin / Curcumin based Injectable Hydrogels

Optimized production of carboxymethyl cellulose/guar gum based durable hydrogel for in vitro performance assessment

Development, in vitro and in vivo evaluation of β-cyclodextrin/Polyvinyl alcohol-co-poly (2-acrylamide-2-methylpropane sulfonic acid) cross-linked hybrid IPN-nanogels to improve the dissolution and absorption of anti-hyperlipidemic drug

Biodegradable Β‐cyclodextrin Conjugated Gelatin Methacryloyl Microneedle for Delivery of Water‐Insoluble Drug

Development, Optimization, and Evaluation of New Gel Formulations with Cyclodextrin Complexes and Volatile Oils with Antimicrobial Activity

Inhibitory potential of rutin and rutin nano-crystals against Helicobacter pylori, colon cancer, hemolysis and Butyrylcholinesterase in vitro and in silico

Fabrication of Rhamnogalacturonan-I Enriched Pectin-Based Emulsion Gels for Protection and Sustained Release of Curcumin

Rutin loaded bilosomes for enhancing the oral activity and nephroprotective effects of rutin in potassium dichromate induced acute nephrotoxicity in rats

Effect of Rutin on the Physicochemical and Gel Characteristics of Myofibrillar Protein under Oxidative Stress

Proniosomal Gel for Topical Delivery of Rutin: Preparation, Physicochemical Characterization and In Vitro Toxicological Profile Using 3D Reconstructed Human Epidermis Tissue and 2D Cells